BIOCLAVIS Trademark

Trademark Overview

On Monday, March 5, 2018, a trademark application was filed for BIOCLAVIS with the United States Patent and Trademark Office. The USPTO has given the BIOCLAVIS trademark a serial number of 87820691. The federal status of this trademark filing is REGISTERED as of Tuesday, November 9, 2021. This trademark is owned by BioClavis Limited. The BIOCLAVIS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Consulting services in the fields of diagnostic medical testing and nutrition; DNA screening for medical purposes; Genetic testing for medical purposes; Medical analysis services for the diagnosis of cancer; Medical diagnosis of oncology, chemotherapy, and inflammatory diseases; Medical diagnostic testing, monitoring and reporting services; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of oncology, chemotherapy, and inflammatory diseases; Providing cancer screening services; Providing health information in the field of oncology, chemotherapy, and inflammatory diseases; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Tissue typing services
bioclavis

General Information

Serial Number87820691
Word MarkBIOCLAVIS
Filing DateMonday, March 5, 2018
Status700 - REGISTERED
Status DateTuesday, November 9, 2021
Registration Number6555470
Registration DateTuesday, November 9, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements

Goods and ServicesConsulting services in the fields of diagnostic medical testing and nutrition; DNA screening for medical purposes; Genetic testing for medical purposes; Medical analysis services for the diagnosis of cancer; Medical diagnosis of oncology, chemotherapy, and inflammatory diseases; Medical diagnostic testing, monitoring and reporting services; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of oncology, chemotherapy, and inflammatory diseases; Providing cancer screening services; Providing health information in the field of oncology, chemotherapy, and inflammatory diseases; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Tissue typing services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, March 11, 2018
Primary Code044
First Use Anywhere DateSaturday, December 19, 2020
First Use In Commerce DateSaturday, December 19, 2020

Trademark Owner History

Party NameBioClavis Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGlasgow G24SQ
GB
Party NameBioClavis Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGlasgow G24SQ
GB
Party NameBioClavis Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGlasgow G24SQ
GB

Trademark Events

Event DateEvent Description
Friday, March 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 9, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, October 5, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, October 3, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 22, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, September 17, 2021USE AMENDMENT FILED
Friday, September 17, 2021TEAS STATEMENT OF USE RECEIVED
Friday, August 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 19, 2021SOU EXTENSION 5 GRANTED
Wednesday, March 17, 2021SOU EXTENSION 5 FILED
Wednesday, March 17, 2021TEAS EXTENSION RECEIVED
Wednesday, October 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2020SOU EXTENSION 4 GRANTED
Friday, September 18, 2020SOU EXTENSION 4 FILED
Wednesday, May 6, 2020SOU EXTENSION 3 GRANTED
Wednesday, March 18, 2020SOU EXTENSION 3 FILED
Sunday, October 6, 2019SOU EXTENSION 2 GRANTED
Wednesday, September 18, 2019SOU EXTENSION 2 FILED
Tuesday, September 15, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, September 15, 2020PETITION GRANTED - EXTENSION REQUEST FILED
Friday, August 28, 2020TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Thursday, July 30, 202030 DAY NOTICE OF INCOMPLETE RESPONSE
Tuesday, July 21, 2020ASSIGNED TO PETITION STAFF
Thursday, March 26, 2020PETITION TO REVIVE-RECEIVED
Wednesday, March 25, 2020TEAS PETITION TO DIRECTOR RECEIVED
Monday, December 16, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 16, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2019SOU EXTENSION 1 GRANTED
Monday, March 18, 2019SOU EXTENSION 1 FILED
Saturday, October 5, 2019NOTICE OF REVIVAL - E-MAILED
Friday, October 4, 2019EXTENSION RECEIVED WITH TEAS PETITION
Friday, October 4, 2019PETITION TO REVIVE-GRANTED
Friday, October 4, 2019TEAS PETITION TO REVIVE RECEIVED
Wednesday, March 27, 2019CORRECTED NOA E-MAILED
Tuesday, March 26, 2019DIVISIONAL PROCESSING COMPLETE
Saturday, March 2, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, March 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, March 2, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 2, 2019TEAS REQUEST TO DIVIDE RECEIVED
Saturday, March 2, 2019TEAS EXTENSION RECEIVED
Tuesday, September 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 16, 2018ASSIGNED TO EXAMINER
Sunday, March 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 8, 2018NEW APPLICATION ENTERED

Related Keywords

bioclavis medical testing services diagnostic purposes information chemotherapy inflammatory field oncology